Vor Biopharma Inc. (VOR) Misses Q3 EPS by 2c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($0.49), $0.02 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04